Case Report: A Near Miss of Pulmonary Embolism in a Division 1 Collegiate Basketball Player

• Published in: Clinical practice and cases in emergency medicine Vol. 4; no. 4; pp. 551 - 554
• Main Authors: Chill, Nicholas, Monseau, Aaron, Balcik, Brenden, Sikora, Rosanna, Oppenlander, Kathryn
• Format: Journal Article
• Language: English
• Published: Irvine University of California Digital Library - eScholarship 01.11.2020; University of California Irvine, Department of Emergency Medicine publishing Western Journal of Emergency Medicine; eScholarship Publishing, University of California
• Subjects: Case Report; Clinical medicine; College basketball; Emergency medical care; Heart rate; Medical imaging; Medicine; Mortality; Pain; Physiology; Pulmonary arteries; Pulmonary embolisms; Risk factors; Student athletes; Ultrasonic imaging; Vital signs
• ISSN: 2474-252X; 2474-252X
• DOI: 10.5811/cpcem.2020.7.47887

Introduction: The clinical presentation of pulmonary embolism (PE) is often associated with classic vital instability such as tachycardia, hypoxia, and tachypnea. This critical diagnosis is often less likely if a patient is negative by Pulmonary Embolism Rule-Out Criteria (PERC) standards with a low pre-test probability of disease. Caution must be used when evaluating elite athletes with the PERC rule due to low resting heart rate and certain risk factors, which are inherent to athletics. Case Report: We report the case of a 20-year-old male Division 1 collegiate athlete with pleuritic chest pain diagnosed with PE despite being PERC negative. His presenting heart rate (HR) of 79 beats per minute was correctly determined to be tachycardic relative to his resting HR of 47-60 beats per minute. Despite his PERC negative status, PE was found after an elevated D-dimer and subsequent computed tomography angiography. Conclusion: Special consideration should be used when evaluating elite athletes for PE, as their resting physiology may differ from the general population. Additionally, certain risk factors for thromboembolic disease are inherent in competitive athletics and should be considered during an initial risk assessment. The presented patient was successfully treated with oral anticoagulation for three months and was able to return to play.